Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Grimmer

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Journal of Alzheimer'S Disease : JAD|July 12, 2021
Age-Dependency of Total Tau in the Cerebrospinal Fluid Is Corrected by Amyloid-β 1-40: A Correlational Study in Healthy AdultsPaul Theo Zebhauser, Achim Berthele, Marie-Sophie Franz, et al.
Scientific Reports|October 12, 2017
Altered neurovascular coupling as measured by optical imaging: a biomarker for Alzheimer's diseaseKonstantin Kotliar, Christine Hauser, Marion Ortner, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2013
Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signaturePanagiotis Alexopoulos, Liang-Hao Guo, Meizi Jiang, et al.
Neurobiology of Aging|March 19, 2008
Clinical severity of Alzheimer's disease is associated with PIB uptake in PETTimo Grimmer, Gjermund Henriksen, Hans-Jürgen Wester, et al.
Neuropsychiatric Disease and Treatment|January 1, 2016
Cerebrospinal fluid biomarkers for Alzheimer's disease: the role of apolipoprotein E genotype, age, and sexShima Mehrabian, Panagiotis Alexopoulos, Marion Ortner, et al.
Brain Imaging and Behavior|December 29, 2021
Neuronavigated repetitive transcranial magnetic stimulation as novel mapping technique provides insights into language function in primary progressive aphasiaFelix Mueller-Sarnowski, Nico Sollmann, Axel Schröder, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 23, 2020
Variability of clinical syndromes and cerebral glucose metabolism in symptomatic frontotemporal lobar degeneration associated with progranulin mutationsAbigail Licata, Timo Grimmer, Juliane Winkelmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2012
Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's diseaseStefan Förster, Behrooz H Yousefi, Hans-Jürgen Wester, et al.
Journal of Proteomics|April 24, 2018
Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approachIlijana Begcevic, Davor Brinc, Marshall Brown, et al.
Translational Neurodegeneration|August 31, 2019
Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PETOliver Goldhardt, Inanna Warnhoff, Igor Yakushev, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Journal of Alzheimer'S Disease : JAD|July 12, 2021
Age-Dependency of Total Tau in the Cerebrospinal Fluid Is Corrected by Amyloid-β 1-40: A Correlational Study in Healthy AdultsPaul Theo Zebhauser, Achim Berthele, Marie-Sophie Franz, et al.
Scientific Reports|October 12, 2017
Altered neurovascular coupling as measured by optical imaging: a biomarker for Alzheimer's diseaseKonstantin Kotliar, Christine Hauser, Marion Ortner, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2013
Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signaturePanagiotis Alexopoulos, Liang-Hao Guo, Meizi Jiang, et al.
Neurobiology of Aging|March 19, 2008
Clinical severity of Alzheimer's disease is associated with PIB uptake in PETTimo Grimmer, Gjermund Henriksen, Hans-Jürgen Wester, et al.
Neuropsychiatric Disease and Treatment|January 1, 2016
Cerebrospinal fluid biomarkers for Alzheimer's disease: the role of apolipoprotein E genotype, age, and sexShima Mehrabian, Panagiotis Alexopoulos, Marion Ortner, et al.
Brain Imaging and Behavior|December 29, 2021
Neuronavigated repetitive transcranial magnetic stimulation as novel mapping technique provides insights into language function in primary progressive aphasiaFelix Mueller-Sarnowski, Nico Sollmann, Axel Schröder, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 23, 2020
Variability of clinical syndromes and cerebral glucose metabolism in symptomatic frontotemporal lobar degeneration associated with progranulin mutationsAbigail Licata, Timo Grimmer, Juliane Winkelmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2012
Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's diseaseStefan Förster, Behrooz H Yousefi, Hans-Jürgen Wester, et al.
Journal of Proteomics|April 24, 2018
Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approachIlijana Begcevic, Davor Brinc, Marshall Brown, et al.
Translational Neurodegeneration|August 31, 2019
Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PETOliver Goldhardt, Inanna Warnhoff, Igor Yakushev, et al.
Pageof 19